CD160 and B-cell chronic lymphocytic leukemia: Moreover, CD160 is aberrantly overexpressed on leukemic cells from patients with CLL and other B-cell malignancies, thus promoting pro-survival and proliferative signaling to tumor cells [52,53,54].